StockData
EHCNYSEServices-HospitalsFiscal year ends December 31

Encompass Health Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$121.71−6.16 (-4.82%)

Close on Oct 19, 2026

Market cap
$12.17B
P/E (TTM)
19.8
Dividend yield
0.59%

About Encompass Health

Services-Hospitals, SIC 8060

Encompass Health operates as a provider of inpatient rehabilitation services, owning and managing specialized hospitals dedicated to post-acute recovery. The organization delivers intensive rehabilitative therapy and medical care to individuals recovering from major illnesses and injuries—including strokes, hip fractures, and debilitating neurological conditions—aiming to restore cognitive and physical functioning. Care is delivered through an interdisciplinary model involving specialized nurses, therapists, and case managers utilizing advanced clinical protocols and technology. Nearly all patients enter these facilities via physician referrals following acute-care hospital stays, with Medicare, Medicare Advantage, and managed care plans serving as the primary sources of payment for these nondiscretionary healthcare services.

As of December 31, 2025, the company operated 173 inpatient rehabilitation hospitals comprising 11,465 licensed beds across 39 U.S. states and Puerto Rico, with substantial concentrations in Florida and Texas. It maintains over a third of its hospitals as joint ventures with acute-care systems and owns the real estate for approximately 79% of its hospital facilities. The organization is based in Birmingham, Alabama, where its principal executive offices are located.

Summary of the business section of Encompass Health's latest annual report, written by StockData.

Company profile

Company

Legal name
Encompass Health Corp
Headquarters
Birmingham, AL
Address
9001 Liberty Parkway 35242
Phone
(205) 967-7116
Employees
42,000, Dec 31, 2025
Industry
Services-Hospitals
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
PricewaterhouseCoopers LLP, Birmingham, Alabama

Stock & identifiers

Ticker
EHC
Exchange
NYSE
Shares outstanding
99M, Jul 28, 2026
Public float
$12.20B, Jun 30, 2025
Filer category
Large accelerated filer
Stock splits
1-for-5 reverse, Oct 26, 2006; 2-for-1, Mar 18, 1997; 2-for-1, Apr 18, 1995; 3-for-2, Jan 2, 1992
SEC CIK
785161
CUSIP
29261A100
ISIN
US29261A1007
LEI
549300FVRPM9DRQZRG64
EIN
63-0860407

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Mark J. TarrPresident & CEO, Director267,814
John Patrick DarbyEVP, Gen Counsel & Secretary79,899
Andrew L. PriceChief Accounting Officer69,483
Douglas E. ColtharpEVP & Chief Financial Officer241,368
Patrick William TuerEVP, Chief Operating Officer24,755
Edmund FaySr. Vice Pres. and Treasurer89,325
Elissa Joy CharbonneauChief Medical Officer17,644
Edward M. Christie IIIDirector9,345
Joan E. HermanDirector49,643
Greg D. CarmichaelDirector20,349
Leslye G. KatzDirector49,643
Nancy M. SchlichtingDirector22,972
Cain A. HayesDirector2,096
Kevin J. O'ConnorDirector11,582
Christopher R. ReidyDirector17,777
Terrance WilliamsDirector16,859
Patricia Anne MarylandDirector14,764

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Mr. Tarr
$10.30M$20.62M$2.87M$170$113
FY2024
Mr. Tarr
$9.30M$17.93M$2.20M$147$95
FY2023
Mr. Tarr
$8.84M$14.07M$2.83M$106$93
FY2022
Mr. Tarr
$7.74M$9.87M$1.93M$94$88
FY2021
Mr. Tarr
$8.25M$6.23M$2.32M$80$110
FY2020
Mr. Tarr
$6.93M$8.45M$2.27M$121$134

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we employed over 42,000 individuals.”

Corporate history

Events identified from SEC filings

DateEventDetails
Jul 7, 2022Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Dec 12, 2017Name changeName changed from HEALTHSOUTH CORP to Encompass Health Corp
Feb 22, 2017DeregistrationTermination of SEC registration (Form 15)
Jan 12, 2017DelistingNotice of delisting from exchange (Form 25)
Jan 29, 2016MergerRegistration of securities for a merger or exchange offer (S-4)
Oct 1, 2015Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jan 2, 2015Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Oct 1, 2009ListingRegistration of securities on an exchange (Form 8-A)
Jul 5, 2007Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Mar 30, 2007MergerRegistration of securities for a merger or exchange offer (S-4)
Sep 13, 2006ListingRegistration of securities on an exchange (Form 8-A)
Aug 8, 2006Late filingNotification of late filing
May 11, 2006Late filingNotification of late filing
Mar 17, 2006Late filingNotification of late filing
Nov 9, 2005Late filingNotification of late filing
Aug 10, 2005Late filingNotification of late filing
May 11, 2005Late filingNotification of late filing
Mar 17, 2005Late filingNotification of late filing
Nov 9, 2004Late filingNotification of late filing
Aug 10, 2004Late filingNotification of late filing
May 11, 2004Late filingNotification of late filing
Mar 16, 2004Late filingNotification of late filing
Aug 14, 2003Late filingNotification of late filing
May 14, 2003Late filingNotification of late filing
Apr 1, 2003Late filingNotification of late filing
Jun 28, 2002MergerRegistration of securities for a merger or exchange offer (S-4)
Nov 19, 2001MergerRegistration of securities for a merger or exchange offer (S-4)
Mar 30, 2001MergerRegistration of securities for a merger or exchange offer (S-4)
Nov 9, 2000MergerRegistration of securities for a merger or exchange offer (S-4)
Aug 14, 1998DeregistrationTermination of SEC registration (Form 15)